NCT06906822
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06906822
Title PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients (PlugIN)
Acronym PlugIN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol Multidisciplinar de Melanoma
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Complexo Hospitalario Universitario de A Coruña RECRUITING A Coruña A Coruña 15006 Spain Details
Institut Català D'Oncologia - Badalona RECRUITING Badalona Barcelona 08916 Spain Details
Hospital Universitari Dexeus NOT_YET_RECRUITING Barcelona Barcelona 08028 Spain Details
Hospital Universitario Valle de Hebrón RECRUITING Barcelona Barcelona 08035 Spain Details
Hospital Clinic de Barcelona RECRUITING Barcelona Barcelona 08036 Spain Details
Hospital Universitario Marqués de Valdecilla RECRUITING Santander Cantabria 39008 Spain Details
Hospital Universitario Ramón y Cajal RECRUITING Madrid Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid Madrid 28041 Spain Details
Hospital Universitario La Paz RECRUITING Madrid Madrid 28046 Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca RECRUITING Murcia Murcia 30120 Spain Details
Hospital Virgen del Rocío RECRUITING Seville Sevilla 41013 Spain Details
Hospital General de Valencia RECRUITING Valencia Valencia 46014 Spain Details
Hospital Universitario Miguel Servet RECRUITING Zaragoza Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field